Sign in:
 Email
 Password  save:
  
 Company Reports 
 
 
Membership is free, please Sign Up.
  
My Recent Searches
  Help
  
   
 
 
Get Insiders for : 
Insmed Inc (INSM)  
$55.94 0.89 (1.62%) as of 4:30 Mon 6/3


Download
   
Exchange: Nasdaq Small Cap
Security Type: Common
Shares Out: 151,572,000
Market Cap: 8.48(B)
Last Volume: 501,923 Avg Vol: 500,553
52 Week Range: $19.24 - $56.98
Level I Sector: Health Care
Level II Sector: Drugs
Level III Sector: Biotechnology

Member Indexes:
    NASDAQ COMPOSITE     NASDAQ NNM COMPOSITE

Rankings:
     
Insider 3 Months    :   -
Insider 6 Months    :   -
Insider 3/6 Months :   -
Guru Rank Number :  -
Guru Rank Value     :  -
Guru Occurances    :  -

 

            6 Months   1 Year   2 Year  
 
Company Profile   Insmed is a biopharmaceutical company. Co.'s commercial product, ARIKAYCE, is approved in the U.S. for the treatment of Mycobacterium avium complex lung disease and in Europe for the treatment of nontuberculous mycobacterial lung infections. Co.'s pipelines include: brensocatib, an oral reversible inhibitor of dipeptidyl peptidase 1 for the treatment of patients with bronchiectasis, cystic fibrosis and other neutrophil-mediated diseases; and treprostinil palmitil inhalation powder, an inhaled formulation of the treprostinil prodrug treprostinil palmitil for pulmonary arterial hypertension and pulmonary hypertension associated with interstitial lung disease.

 
 
Summary  (Direct Transactions Only) 3 Months 6 Months 12 Months 24 Months
Total Shares Bought 0 0 0 95,000
Total Buy Value $0 $0 $0 $1,709,450
Total People Bought 0 0 0 2
Total Buy Transactions 0 0 0 5
Total Shares Sold 525,422 694,534 825,123 1,226,977
Total Sell Value $24,358,586 $29,388,785 $32,444,566 $42,349,832
Total People Sold 7 7 7 7
Total Sell Transactions 16 37 41 74
End Date 2024-03-03 2023-12-01 2023-06-02 2022-06-02

   
Records found: 584
  Page 20 of 24  
Filer's Name Relation Title Off-Dir-10% Tran. Date Form Action Price Mkt Value D/I Shares Holdings
Rank

  
3m +/-  
Form
   Engelsen Steinar J Director   –       •      –    2013-01-14 4 OE $0.00 $0 D/D 10,174 218,103     -
   Lewis William President and CEO   •       –      –    2013-01-09 4 AB $6.90 $74,313 D/D 10,770 24,338     -
   Lewis William President and CEO   •       –      –    2012-12-03 4 AB $7.36 $99,860 D/D 13,568 13,568     -
   Fmr Corp 10% Owner   –       –       •   2012-10-25 3 IO $0.00 $0 I/I 0 1,881,752     -
   Venkatesan Jay 10% Owner   –       –       •   2012-09-28 3 IO $0.00 $0 I/I 0 3,116,100     -
   Sharoky Melvin Md Director   –       •      –    2012-06-14 4 B $3.00 $59,808 D/D 19,936 147,773 2.39     -
   Engelsen Steinar J Director   –       •      –    2012-06-04 4 B $0.00 $0 D/D 4,360 207,929 2.31     -
   Sharoky Melvin Md Director   –       •      –    2012-06-04 4 B $0.00 $0 D/D 20,000 127,837 2.31     -
   Engelsen Steinar J Director   –       •      –    2012-06-01 4 B $0.00 $0 D/D 61,618 203,569 2.31     -
   Whitten Timothy President & CEO   •       •      –    2012-06-01 4 B $2.91 $21,791 D/D 7,500 10,000 2.81     -
   Sharoky Melvin Md Director   –       •      –    2012-01-23 4 OE $0.00 $0 D/D 5,469 86,637     -
   Whitcomb Randall W Director   –       •      –    2012-01-23 4 OE $0.00 $0 D/D 5,469 37,409     -
   Kollender Richard S Director   –       •      –    2012-01-23 4 OE $0.00 $0 D/D 5,469 5,469     -
   Hayden Donald J Jr Director   –       •      –    2012-01-23 4 OE $0.00 $0 D/D 8,594 27,594     -
   Engelsen Steinar J Director   –       •      –    2012-01-23 4 OE $0.00 $0 D/D 5,469 141,951     -
   Sharoky Melvin Md Director   –       •      –    2011-04-11 4 B $7.63 $131,757 D/D 17,266 80,725 2.39     -
   Sharoky Melvin Md Director   –       •      –    2011-04-08 4 B $7.64 $56,155 D/D 7,352 63,459 2.39     -
   Whitten Timothy President & CEO   •       –      –    2011-03-30 4 B $6.58 $16,450 D/D 2,500 2,500 2.74     -
   Hayden Donald J Jr Director   –       •      –    2011-03-29 4 B $6.36 $13,992 D/D 2,200 12,937 2.39     -
   Whitcomb Randall W Director   –       •      –    2011-03-28 4 B $6.54 $32,680 D/D 5,000 29,840 2.39     -
   Engelsen Steinar J Director   –       •      –    2011-03-28 4 B $6.60 $3,254 D/D 493 136,482 2.31     -
   Gupta Renu EVP & Chief Medical Officer   •       –      –    2011-03-28 4 B $6.50 $6,500 D/D 1,000 2,000 2.74     -
   Hayden Donald J Jr Director   –       •      –    2011-03-25 4/A B $5.47 $38,290 D/D 7,000 19,000 2.39     -
   Gupta Renu EVP & Chief Medical Officer   •       –      –    2011-03-25 4 B $6.15 $6,150 D/D 1,000 1,000 2.74     -
   Hayden Donald J Jr Director   –       •      –    2011-03-25 4 B $5.42 $7,247 D/D 1,337 10,737 2.39     -
  584 Records found
  Previous  20  21  22  23  24   
  Page 20 of 24
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
  OE - Options Exercised A - Acquired
  IO - Initital Ownership D - Disposed
 
 
    Copyright © 2024 j3sg.com | Disclaimer & Terms of use          Products & Service  About Us  Contact Us